Jonathan Schoenfeld on Collaboration for Combination Therapy
Dr. Jonathan Schoenfeld discusses the need for collaboration among teams when a patient is receiving a combination of immunotherapy and radiation treatment.
Jonathan Schoenfeld, MD, MPhil, MPH, of Dana-Farber Cancer Institute, talks about the collaboration between teams for patients who are receiving combination therapies.
When it comes to a combined treatment plan of radiation and immunotherapy, both radiation and medical oncologists must be involved. Additionally, with the potential of immune-related adverse events, Schoenfeld suggests the inclusion of gastroenterologists, dermatologists, and endocrinologists.
Stopping ICIs at 1 or 2 Years May Not Compromise Survival in HNSCC
September 11th 2024This retrospective, population-based study shows strong efficacy across multiple patient subgroups and different lines of therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma.
